Discovering Cell‐Targeting Ligands and Cell‐Surface Receptors by Selection of DNA‐Encoded Chemical Libraries against Cancer Cells without Predefined Targets
Yuhan Gui,
No information about this author
Rui Hou,
No information about this author
Yuchen Huang
No information about this author
et al.
Angewandte Chemie,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 11, 2025
Abstract
Small
molecules
that
can
bind
to
specific
cells
have
broad
application
in
cancer
diagnosis
and
treatment.
Screening
large
chemical
libraries
against
live
is
an
effective
strategy
for
discovering
cell‐targeting
ligands.
The
DNA‐encoded
library
(DEL
or
DECL)
technology
has
emerged
as
a
robust
tool
drug
discovery
been
successfully
utilized
identifying
ligands
biological
targets.
However,
nearly
all
DEL
selections
predefined
targets,
while
target‐agnostic
interrogating
the
entire
cell
surface
remain
underexplored.
Herein,
we
systematically
optimized
cell‐based
selection
method
without
A
104.96‐million‐member
was
selected
MDA‐MB‐231
MCF‐7
breast
cells,
representing
high
low
metastatic
properties,
respectively,
which
led
identification
of
cell‐specific
small
molecules.
We
further
demonstrated
applications
these
photodynamic
therapy
targeted
delivery.
Finally,
leveraging
DNA
tag
compounds,
identified
α‐enolase
(ENO1)
receptor
one
targeting
more
aggressive
cells.
Overall,
this
work
offers
efficient
approach
molecule
by
using
DELs
demonstrates
be
useful
identify
receptors
on
Language: Английский
Discovering Cell‐Targeting Ligands and Cell‐Surface Receptors by Selection of DNA‐Encoded Chemical Libraries against Cancer Cells without Predefined Targets
Yuhan Gui,
No information about this author
Rui Hou,
No information about this author
Yuchen Huang
No information about this author
et al.
Angewandte Chemie International Edition,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 11, 2025
Abstract
Small
molecules
that
can
bind
to
specific
cells
have
broad
application
in
cancer
diagnosis
and
treatment.
Screening
large
chemical
libraries
against
live
is
an
effective
strategy
for
discovering
cell‐targeting
ligands.
The
DNA‐encoded
library
(DEL
or
DECL)
technology
has
emerged
as
a
robust
tool
drug
discovery
been
successfully
utilized
identifying
ligands
biological
targets.
However,
nearly
all
DEL
selections
predefined
targets,
while
target‐agnostic
interrogating
the
entire
cell
surface
remain
underexplored.
Herein,
we
systematically
optimized
cell‐based
selection
method
without
A
104.96‐million‐member
was
selected
MDA‐MB‐231
MCF‐7
breast
cells,
representing
high
low
metastatic
properties,
respectively,
which
led
identification
of
cell‐specific
small
molecules.
We
further
demonstrated
applications
these
photodynamic
therapy
targeted
delivery.
Finally,
leveraging
DNA
tag
compounds,
identified
α‐enolase
(ENO1)
receptor
one
targeting
more
aggressive
cells.
Overall,
this
work
offers
efficient
approach
molecule
by
using
DELs
demonstrates
be
useful
identify
receptors
on
Language: Английский
Identification of Structurally Novel KRASG12C Inhibitors through Covalent DNA-Encoded Library Screening
David Huang,
No information about this author
Francesco Manoni,
No information about this author
Zhen Sun
No information about this author
et al.
Journal of Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 11, 2025
Covalent
inhibition
of
the
KRASG12C
oncoprotein
has
emerged
as
a
promising
therapeutic
approach
for
treatment
nonsmall
cell
lung
cancer
(NSCLC).
The
identification
inhibitors
typically
relied
on
high-throughput
screening
(HTS)
libraries
cysteine-reactive
small
molecules
or
attachment
warheads
to
noncovalent
binders
KRAS.
Such
approaches
have
historically
been
limited
in
size
and
diversity
that
could
be
effectively
screened.
DNA-encoded
library
(DEL)
accelerate
preparation
incredibly
large
diverse
chemical
libraries.
Here,
we
describe
design
synthesis
covalent
DEL
screen
∼16
million
compounds
against
KRASG12C.
We
additionally
hit
identification,
validation,
structure-based
optimization
culminated
series
structurally
novel,
potent,
selective
with
good
pharmacokinetic
profiles
vivo
pharmacodynamic
effects.
Language: Английский
Photochemical-Promoted Cross-Coupling Reaction of Alkyl Boronate Esters with DNA-Conjugated Aryl Bromides for DNA-Encoded Library Synthesis
Baiyang Mu,
No information about this author
Yiwei Zhang,
No information about this author
Xudong Wang
No information about this author
et al.
Bioconjugate Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
The
C(sp2)-C(sp3)
cross-coupling
reaction
is
an
effective
way
to
increase
the
C(sp3)
content
in
compound
collections
for
drug
discovery,
enhancing
molecular
diversity
and
offering
a
unique
chemistry
starting
point.
In
this
study,
we
report
mild,
DNA-compatible,
off-DNA-inert
photochemical
inspired
by
amino
radical
transfer
strategy.
This
method
demonstrates
broad
substrate
scopes
DNA-encoded
library
(DEL)
constructions,
utilizing
commonly
available
structures
on
DNA
diverse
alkyl
boronate
ester
building
blocks,
which
have
not
been
widely
applied
current
DEL
chemical
space.
Language: Английский
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors
Xudong Wang,
No information about this author
Liwei Xiong,
No information about this author
Ying Zhu
No information about this author
et al.
Journal of the American Chemical Society,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 22, 2024
The
COVID-19
pandemic,
exacerbated
by
persistent
viral
mutations,
underscored
the
urgent
need
for
diverse
inhibitors
targeting
multiple
proteins.
In
this
study,
we
utilized
covalent
DNA-encoded
libraries
to
discover
innovative
triazine-based
3-chymotrypsin-like
protease
(3CLpro,
Nsp5)
and
papain-like
(PLpro)
domains
of
Nsp3,
as
well
novel
non-nucleoside
nonstructural
protein
12
(Nsp12,
RdRp).
Optimization
through
molecular
docking
medicinal
chemistry
led
development
LU9,
a
nonpeptide
3CLpro
inhibitor
with
an
IC50
0.34
μM,
LU10,
whose
crystal
structure
showed
distinct
binding
mode
within
active
site.
X-ray
cocrystal
SARS-CoV-2
PLpro
in
complex
XD5
uncovered
previously
unexplored
site
adjacent
catalytic
pocket.
Additionally,
Nsp12
XJ5
achieved
potency
0.12
μM
following
comprehensive
structure–activity
relationship
analysis
optimization.
Molecular
dynamics
revealed
potential
mode.
These
compounds
offer
valuable
chemical
probes
target
validation
represent
promising
candidates
antiviral
therapies.
Language: Английский